Literature DB >> 12601175

Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin.

Hideki Shimodaira1, Atsuko Yoshioka-Yamashita, Richard D Kolodner, Jean Y J Wang.   

Abstract

Mismatch repair (MMR) proteins contribute to genome integrity by correcting replication errors. In higher eukaryotes, MMR proteins also regulate the cellular response to DNA lesions such as oxidized, alkylated, or crosslinked bases. Previous studies have linked MMR proteins to the activation of apoptosis through p53-dependent and p53-independent mechanisms. MMR-deficient cells exhibit variable defects in the induction of p53 and its related p73, which are activators of apoptosis. However, the specific role of each MMR protein in the regulation of apoptosis has not been determined. Here, we describe an interaction between PMS2, an MMR protein, and p73. This interaction causes the stabilization of p73 and the redistribution of PMS2 to the nuclear compartment. Exposure to cisplatin enhances the association between PMS2 and p73. Moreover, stimulation of the p73 proapoptotic function by cisplatin requires PMS2. These results suggest that PMS2 contributes to genome integrity not only through DNA repair but also by enhancing DNA damage-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12601175      PMCID: PMC151356          DOI: 10.1073/pnas.0438031100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  50 in total

1.  MSH2 and MSH6 are required for removal of adenine misincorporated opposite 8-oxo-guanine in S. cerevisiae.

Authors:  T T Ni; G T Marsischky; R D Kolodner
Journal:  Mol Cell       Date:  1999-09       Impact factor: 17.970

2.  Mismatch repair processing of carcinogen-DNA adducts triggers apoptosis.

Authors:  J Wu; L Gu; H Wang; N E Geacintov; G M Li
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

3.  BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures.

Authors:  Y Wang; D Cortez; P Yazdi; N Neff; S J Elledge; J Qin
Journal:  Genes Dev       Date:  2000-04-15       Impact factor: 11.361

4.  Loss of DNA mismatch repair in acquired resistance to cisplatin.

Authors:  S Aebi; B Kurdi-Haidar; R Gordon; B Cenni; H Zheng; D Fink; R D Christen; C R Boland; M Koi; R Fishel; S B Howell
Journal:  Cancer Res       Date:  1996-07-01       Impact factor: 12.701

5.  MLH3: a DNA mismatch repair gene associated with mammalian microsatellite instability.

Authors:  S M Lipkin; V Wang; R Jacoby; S Banerjee-Basu; A D Baxevanis; H T Lynch; R M Elliott; F S Collins
Journal:  Nat Genet       Date:  2000-01       Impact factor: 38.330

6.  Identification of hMutLbeta, a heterodimer of hMLH1 and hPMS1.

Authors:  M Räschle; G Marra; M Nyström-Lahti; P Schär; J Jiricny
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

7.  Apoptosis induced by overexpression of hMSH2 or hMLH1.

Authors:  H Zhang; B Richards; T Wilson; M Lloyd; A Cranston; A Thorburn; R Fishel; M Meuth
Journal:  Cancer Res       Date:  1999-07-01       Impact factor: 12.701

8.  hMutSalpha- and hMutLalpha-dependent phosphorylation of p53 in response to DNA methylator damage.

Authors:  D R Duckett; S M Bronstein; Y Taya; P Modrich
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

9.  Heterozygous DNA mismatch repair gene PMS2-knockout mice are susceptible to intestinal tumor induction with N-methyl-N-nitrosourea.

Authors:  X Qin; D Shibata; S L Gerson
Journal:  Carcinogenesis       Date:  2000-04       Impact factor: 4.944

10.  Evidence for a recessive inheritance of Turcot's syndrome caused by compound heterozygous mutations within the PMS2 gene.

Authors:  M De Rosa; C Fasano; L Panariello; M I Scarano; G Belli; A Iannelli; F Ciciliano; P Izzo
Journal:  Oncogene       Date:  2000-03-23       Impact factor: 9.867

View more
  53 in total

1.  Diagnosing Lynch syndrome: is the answer in the mouth?

Authors:  H K Roy; H T Lynch
Journal:  Gut       Date:  2003-12       Impact factor: 23.059

2.  p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2.

Authors:  Marshall Urist; Tomoaki Tanaka; Masha V Poyurovsky; Carol Prives
Journal:  Genes Dev       Date:  2004-12-15       Impact factor: 11.361

3.  Identification of the mismatch repair genes PMS2 and MLH1 as p53 target genes by using serial analysis of binding elements.

Authors:  Jiguo Chen; Ivan Sadowski
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-21       Impact factor: 11.205

4.  Mismatch repair proteins are activators of toxic responses to chromium-DNA damage.

Authors:  Elizabeth Peterson-Roth; Mindy Reynolds; George Quievryn; Anatoly Zhitkovich
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

5.  Role of mismatch repair proteins in the processing of cisplatin interstrand cross-links.

Authors:  Akshada Sawant; Anbarasi Kothandapani; Anatoly Zhitkovich; Robert W Sobol; Steve M Patrick
Journal:  DNA Repair (Amst)       Date:  2015-10-23

6.  Significant associations of mismatch repair gene polymorphisms with clinical outcome of pancreatic cancer.

Authors:  Xiaoqun Dong; Li Jiao; Yanan Li; Douglas B Evans; Huamin Wang; Kenneth R Hess; James L Abbruzzese; Donghui Li
Journal:  J Clin Oncol       Date:  2009-02-23       Impact factor: 44.544

Review 7.  Versatile functions of p53 protein in multicellular organisms.

Authors:  P M Chumakov
Journal:  Biochemistry (Mosc)       Date:  2007-12       Impact factor: 2.487

8.  Stabilization of mismatch repair gene PMS2 by glycogen synthase kinase 3beta is implicated in the treatment of cervical carcinoma.

Authors:  Yuan Zhang; Yi Min Shu; Shu Fang Wang; Bang Hong Da; Ze Hua Wang; Hua Bin Li
Journal:  BMC Cancer       Date:  2010-02-23       Impact factor: 4.430

9.  Cellular responses to Cisplatin-induced DNA damage.

Authors:  Alakananda Basu; Soumya Krishnamurthy
Journal:  J Nucleic Acids       Date:  2010-08-08

10.  p73alpha is a candidate effector in the p53 independent apoptosis pathway of cisplatin damaged primary murine colonocytes.

Authors:  A Oniscu; N Sphyris; R G Morris; S Bader; D J Harrison
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.